Literature DB >> 10526950

Successful treatment of cerebral aspergillosis with a high oral dose of itraconazole after excisional surgery.

T Imai1, T Yamamoto, S Tanaka, M Kashiwagi, S Chiba, H Matsumoto, T Uede.   

Abstract

We report a case of cerebral aspergillosis which originated from the sphenoid sinus, and involved a progressive decrease of visual acuity. The neurological signs indicated a cavernous sinus invasion. After extensive intracranial surgery we treated the residual aspergillosis with a high oral dose of itraconazole (800 mg/d for 4 months, followed by 400 mg/d for 5 months). The neurological impairments of the patient gradually subsided with the resolution of the fungal lesion shown on MRI. The successful therapy indicated that itraconazole has a significant role in the treatment of advanced cerebral aspergillosis if it is used in high doses (16 mg/kg/d for adults).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526950     DOI: 10.2169/internalmedicine.38.829

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Medical management of invasive fungal infections of the central nervous system in pediatric cancer patients.

Authors:  John H Carter; Jennifer L Lenahan; Gisele E Ishak; J Russell Geyer; Jessica Pollard; Janet A Englund
Journal:  Pediatr Blood Cancer       Date:  2014-11-18       Impact factor: 3.167

Review 2.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Invasive sphenoid sinus aspergillosis mimicking sellar tumor: a report of 4 cases and systematic literature review.

Authors:  Hanwen Zhang; Nian Jiang; Xuelei Lin; Siyi Wanggou; Jeffrey J Olson; Xuejun Li
Journal:  Chin Neurosurg J       Date:  2020-04-09

4.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

5.  Central nervous system Aspergillus fumigatus infection after near drowning.

Authors:  P A Kowacs; S Monteiro de Almeida; R L Pinheiro; H Fameli; E J Piovesan; A Correia; L C Werneck
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

Review 6.  CNS aspergillosis: recognition, diagnosis and management.

Authors:  Markus Ruhnke; Grzegorz Kofla; Kirsten Otto; Stefan Schwartz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways.

Authors:  Guanzhao Liang; Musang Liu; Qiong Wang; Yongnian Shen; Huan Mei; Dongmei Li; Weida Liu
Journal:  Oncotarget       Date:  2017-04-25

Review 8.  Central Nervous System Infections Due to Aspergillus and Other Hyaline Molds.

Authors:  Marisa H Miceli
Journal:  J Fungi (Basel)       Date:  2019-08-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.